Cecília M. P. Rodrigues, PhD is Head of the Department of Biochemistry and Human Biology, Faculty of Pharmacy, University of Lisbon, Portugal. She graduated in Pharmaceutical Sciences from the University of Lisbon in 1992, and received her PhD in Biochemistry from the same University in 1996, after PhD training at the University of Cincinnati, Cincinnati, OH, USA, under the supervision of Kenneth D. R. Setchell, PhD. This was followed by postdoctoral work at the University of Minnesota, Minneapolis, MN, USA, under the supervision of Clifford J. Steer, MD. Since December 2009, she is Full Professor, at the University of Lisbon, where she also leads the research group Molecular and Cell Biology of Eukaryotic Systems, within the Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL).
She is member of the American Association for the Study of Liver Disease (AASLD), the European Association for the Study of the Liver (EASL), the American Society of Biochemistry and Molecular Biology (ASBMB), the Federation of American Societies for Experimental Biology (FASEB). She has received honours and scientific awards including the Young Investigator’s Award 1999 (EASL); EASL Fellowship Laureate (2000); Pulido Valente Prize – Science 2003 (Pulido Valente Foundation and FCT, Portugal).
Her central scientific interests aim at understanding liver disease mechanisms and identifying drug targets in the discovery phase of the development chain, as well as validating novel drug targets and intervention strategies at the pre-clinical level. She focuses on specific product platforms such as small molecules, RNA/DNA, genes or cells. The ultimate goal is to control specific gene expression and signalling networks involved in cell death, differentiation and proliferation.